Sotalol Hydrochloride Tablet
Product Images NDC 72162-1931

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 72162-1931). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Age About 2 Years Or Younger (Age Factor)

FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
This text appears to be reporting p-values for different doses of oral Sotalol compared to a placebo in terms of recurrence-free survival. The p-values for the different doses are listed as follows: 80 mg (p=0.325), 120 mg (p=0.018), and 160 mg (p=0.029). These p-values are used to assess the statistical significance of the treatment effect and determine if there is a significant difference in recurrence-free survival between the different doses of oral Sotalol and the placebo.*
FDA Label Image

Figure 3 (Figure3)

FDA Label Image

Label (Lbl721621931)

FDA Label Image

Molecular Structure (Molecularstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.